Thomas Jefferson University, Division on Pulmonary and Critical Care — Philadelphia, Pennsylvania

Thomas Jefferson University, Division on Pulmonary and Critical Care is a clinical research site located in Philadelphia, Pennsylvania, United States 19107-5109.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Thomas Jefferson University, Division on Pulmonary and Critical Care has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Actelion.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University, Division on Pulmonary and Critical Care?

Thomas Jefferson University, Division on Pulmonary and Critical Care has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University, Division on Pulmonary and Critical Care conducted?

Thomas Jefferson University, Division on Pulmonary and Critical Care has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Thomas Jefferson University, Division on Pulmonary and Critical Care accredited by Crixeo Clinical Trials?

Thomas Jefferson University, Division on Pulmonary and Critical Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University, Division on Pulmonary and Critical Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.